Yalu Yan

Yalu Yan

Auto-generated profile, based on publicly available information

Yalu Yan

Inner Mongolia Yili Industrial Group, Co. Ltd, Yili Maternal and Infant Nutrition Institute (YMINI), Beijing 100070, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Current Opinion in Food Science
Verified
Journal Article
Closed access
YYYa Lu Yan
Ya Lu Yan
YHYing Hu
Ying Hu
Michael GanzleMichael Ganzle
Michael Ganzle

25 September 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LZLimeng Zhu
Limeng Zhu
RLRuilian Li
Ruilian Li
SJsiming jiao
siming jiao
JWJinhua Wei
Jinhua Wei
YYYalu Yan
Yalu Yan
YDYuguang Du
Yuguang Du
It is proven that β-amyloid (Aβ) aggregates containing cross-β-sheet structures led to oxidative stress, neuroinflammation, and neuronal loss via multiple pathways. Therefore, reduction of Aβ neurotoxicity via inhibiting aggregation of Aβ or dissociating toxic Aβ aggregates into nontoxic forms might be effective therapeutic methods for Alzheimer’s disease (AD) treatment. This study was designed to explore interference of chitosan oligosaccharides (COS) on β-(1-42)-amyloid protein (Aβ42) aggregation and Aβ42-induced cytotoxicity. Here it was demonstrated that COS showed good blood-brain barrier (BBB) penetration ability in vitro and in vivo. The experimental results showed that COS efficiently interfered with Aβ42 aggregation in dose- and degree of polymerization (DP)-dependent manners, and COS monomer with DP6 showed the best effect on preventing conformational transition into β-sheet-rich structures. Based on the binding affinity analysis by microscale thermophoresis (MST), it was confirmed that COS could directly bind with Aβ42 in a DP-dependent manner. Our findings demonstrated that different performance of COS monomers with different DPs against Aβ42 assembly was, to some extent, attributable to their different binding capacities with Aβ42. As a result, COS significantly ameliorated Aβ42-induced cytotoxicity. Taken together, our studies would point towards a potential role of COS in treatment of AD.

22 March 2024 in Food Bioscience
Verified
Journal Article
Closed access
MHMengyu Han
Mengyu Han
XWXuemin Wang
Xuemin Wang
KZKai Zhang
Kai Zhang
ISIgnatius Man-Yau Szeto
Ignatius Man-Yau Szeto
SDSufang Duan
Sufang Duan
PZPeng Zhou
Peng Zhou

8 June 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
YYYa Lu Yan
Ya Lu Yan
YHYing Hu
Ying Hu
DSDavid Simpson
David Simpson
Michael GanzleMichael Ganzle
Michael Ganzle

20 August 2024 in Food Bioscience
Verified
Journal Article
Closed access
LZLina Zhang
Lina Zhang
JZJinyue Zhang
Jinyue Zhang
YYYalu Yan
Yalu Yan
SDSufang Duan
Sufang Duan
XWXuemin Wang
Xuemin Wang
PZPeng Zhou
Peng Zhou

28 April 2025 in Food & Function
Verified
Journal Article
Closed access
PDF file
RZRui Zhang
Rui Zhang
SDSufang Duan
Sufang Duan
XMXinming Ma
Xinming Ma
ZGZhengtao Guo
Zhengtao Guo
ISIgnatius Man-Yau Szeto
Ignatius Man-Yau Szeto
BLBailiang Li
Bailiang Li
2′-FL and OPN synergistically alleviates LPS-induced intestinal barrier damage in rats via improved barrier function, reduced inflammation, balanced immunity, and modulated microbiota.